These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8856748)

  • 1. Antimicrobial resistance: an overview.
    Solomkin JS
    New Horiz; 1996 Aug; 4(3):319-20. PubMed ID: 8856748
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial resistance: factors and outcomes.
    Fish DN; Ohlinger MJ
    Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nosocomial infections at intensive care units. Don't give germs a chance!].
    Sandrock B
    Krankenpfl Soins Infirm; 1999 May; 92(5):8-11. PubMed ID: 10514685
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of programs to decrease antimicrobial resistance in the intensive care unit.
    Hall CS; Ost DE
    Semin Respir Infect; 2003 Jun; 18(2):112-21. PubMed ID: 12840792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals.
    Fridkin SK; Steward CD; Edwards JR; Pryor ER; McGowan JE; Archibald LK; Gaynes RP; Tenover FC
    Clin Infect Dis; 1999 Aug; 29(2):245-52. PubMed ID: 10476720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance in the intensive care unit: impact of new patterns.
    McGowan J; Tenover F
    Int J Clin Pract Suppl; 1998 Jun; 95():14-22. PubMed ID: 9796551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notice of availability of funds; economic and outcome analysis of antimicrobial resistance in hospital-acquired infections among intensive care unit patients--CDC.
    Fed Regist; 1998 Sep; 63(175):48510-3. PubMed ID: 10182832
    [No Abstract]   [Full Text] [Related]  

  • 8. ICUs called good target for anti-resistance efforts.
    Healthc Benchmarks; 1997 Oct; 4(10):148-50. PubMed ID: 10173378
    [No Abstract]   [Full Text] [Related]  

  • 9. Routine cycling of antimicrobial agents as an infection-control measure.
    Fridkin SK
    Clin Infect Dis; 2003 Jun; 36(11):1438-44. PubMed ID: 12766840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) System.
    Am J Infect Control; 1999 Jun; 27(3):279-84. PubMed ID: 10358233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic resistance in the European countries].
    Carlet J
    Pathol Biol (Paris); 1998 Apr; 46(4):213-6. PubMed ID: 9769900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selective decontamination of digestive tract. A way to control intensive care infections].
    Blomqvist H; Burman L; Ekwall E
    Lakartidningen; 2004 Mar; 101(11):966-7. PubMed ID: 15055116
    [No Abstract]   [Full Text] [Related]  

  • 13. Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care units.
    Flournoy DJ; Reinert RL; Bell-Dixon C; Gentry CA
    Am J Infect Control; 2000 Jun; 28(3):244-50. PubMed ID: 10840345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of infections caused by drug-resistant organisms in critical care.
    Hoppe B
    Am J Crit Care; 1997 Mar; 6(2):141-4. PubMed ID: 9172851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
    Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD
    J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of infection control on intensive care unit microbial isolates.
    Kapadia F; Rodrigues C; Mohib M; Menon S; Hakimiyan A; Mehta A
    J Assoc Physicians India; 1998 Aug; 46(8):695-8. PubMed ID: 11229275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance in critical care.
    Smith MA; McInnis LA
    Crit Care Nurs Clin North Am; 2007 Mar; 19(1):53-60. PubMed ID: 17338950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intensive care unit in antimicrobial resistance.
    Koleff MH
    Postgrad Med; 2001 Feb; 109(2 Suppl):60-9. PubMed ID: 19667559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units.
    Blot S
    Clin Microbiol Infect; 2008 Jan; 14(1):5-13. PubMed ID: 17944969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of antibiotic resistance in European ICUs.
    Hanberger H; Diekema D; Fluit A; Jones R; Struelens M; Spencer R; Wolff M
    J Hosp Infect; 2001 Jul; 48(3):161-76. PubMed ID: 11439002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.